ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Nutrition, Disease Oriented Contracts

December 4, 1981

Advocates Oppose Proposals to Market Drugs After Phase I.

June 9, 2006

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

NCI Unveils Checklist for Omics Studies

February 7, 2013